A new Chemo-enzymatic process for the synthesis of Pregabalin; M.Sc. in Biological Sciences, Microbiology, Biotechnology , Biochemistry, Life Science, Biochemical Engineering or Technology from a recognized University or equivalent.
A Phase-lV, single-arm, multicentric study to assess the safety of SIIPLs qHPV vaccineCERVAVAC when administered in a two-dose schedule to girls and boys aged 9-14 years and in a three dose schedule to women and men aged 15-26
Candidates holding Postgraduate, Master’s degree M.Sc. , M.Tech. , M.Pharm etc. Two Years Course in the area related to life sciences including botany, chemistry, biochemistry, biotechnology, agriculture sciences, microbiology, plant sciences, pharmaceutical chemistry, food technology
M.Pharm, M.Sc, M.Tech Bioinformatics, Pharmaceutical Chemistry or Biotechnology. Experience in Molecular Modelling, Computer-aided drug design, ML, AI skills with experience in various tools
B. Pharm, B.Sc. for BA BE and For clinical B. Pharma or M.Sc. Or M.B.B.S.B. V. Sc. and A.H is compulsory. M. V. Sc. Pharmacology and Toxicology is desirable for preclinical; Check CROs for conducting preclinical/ clinical/ bio equivalence studies by site feasibility/ selection visits or evaluation for ensuring adequate facility, skill and experience for conducting the studies as per requirements
Dossier and document preparation as per CTD,ACTD and country specific guidelines, Review of dossiers, DMF and Technical documents, Answer query raised from regulatory authority, package insert, SmPC, PIL & MSDS preparation
M.Pharm / M.Sc. jobs; Analysis of Finished product, Method development, validation, Documentation as per GLP Stability analysis of finished products, calibration of instruments